Sato, Shunsuke
Kawai, Hidehiko
Sato, Sho
Iwasaki, Hirohiko
Omori, Masashi
Kita, Yuji
Ikeda, Yuji
Awatsu, Takahito
Murata, Ayato
Taniguchi, Gentaro
Shimada, Yuji
Genda, Takuya
Article History
Received: 2 May 2022
Accepted: 11 November 2022
First Online: 21 November 2022
Declarations
:
: The study protocol was approved by the Juntendo University Shizuoka Hospital’s Ethics Committee (No.829), and performed in accordance with the 2013 revision of the Helsinki Declaration. Written informed consent was obtained from all patients.
: Not applicable.
: TG has received honoraria from AbbVie, Gilead Sciences Inc., and MSD K.K. and research funding from AbbVie, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma, JIMRO Co. Ltd, and Takeda Pharmaceutical.